Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
|
IONIS PHARMACEUTICALS INC (IONS)
|
Add to portfolio |
|
|
|
| Price: |
$32.60
| | Metrics |
| OS: |
143.3
|
M
| |
-72
|
% ROE
|
| Market cap: |
$4.67
|
B
| |
-23
|
% ROIC
|
|
Net cash:
|
$2.84
|
B
| |
$19.83
|
per share
|
|
EV:
|
$1.83
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($471)
|
M
| |
|
|
| EPS |
($2.16)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 587.4 | 810.5 | 729.3 | 1,122.6 | 599.7 | 514.2 | 372.8 | 283.7 |
| Revenue growth | -27.5% | 11.1% | -35.0% | 87.2% | 16.6% | 37.9% | 31.4% | 32.5% |
| Cost of goods sold | 14.1 | 10.8 | 11.9 | 4.4 | 1.8 | 374.6 | 0.0 | 0.0 |
| Gross profit | 573.3 | 799.6 | 717.3 | 1,118.2 | 597.9 | 139.5 | 372.8 | 283.7 |
| Gross margin | 97.6% | 98.7% | 98.4% | 99.6% | 99.7% | 27.1% | 100.0% | 100.0% |
| Selling, general and administrative | 150.3 | 186.3 | 354.3 | 286.6 | 244.6 | 108.5 | 48.6 | 37.2 |
| Research and development | | | | | | | | |
| EBITA | -407.8 | -27.8 | -170.0 | 367.8 | -59.6 | 32.7 | -18.6 | -74.4 |
| EBITA margin | -69.4% | -3.4% | -23.3% | 32.8% | -9.9% | 6.4% | -5.0% | -26.2% |
| Amortization of intangibles | 2.4 | 2.4 | 2.1 | 1.9 | 1.8 | 1.6 | 1.6 | 1.4 |
| EBIT | -410.2 | -30.2 | -172.1 | 365.9 | -61.4 | 31.0 | -20.2 | -75.8 |
| EBIT margin | -69.8% | -3.7% | -23.6% | 32.6% | -10.2% | 6.0% | -5.4% | -26.7% |
| Pre-tax income | -258.0 | -29.1 | -134.6 | 338.8 | -76.2 | -16.8 | -57.5 | -87.9 |
| Income taxes | 11.7 | -0.6 | 345.2 | 51.5 | -291.1 | -6.0 | 2.9 | 0.4 |
| Tax rate | | 1.9% | | 15.2% | 382.3% | 35.7% | | |
| Net income | -269.7 | -28.6 | -444.3 | 278.1 | 273.7 | 0.3 | -60.4 | -88.3 |
| Net margin | -45.9% | -3.5% | -60.9% | 24.8% | 45.6% | 0.1% | -16.2% | -31.1% |
| |
| Diluted EPS | ($1.90) | ($0.20) | ($3.18) | $1.82 | $2.04 | $0.00 | ($0.50) | ($0.74) |
| Shares outstanding (diluted) | 141.8 | 141.0 | 139.6 | 153.2 | 134.1 | 126.1 | 120.9 | 119.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|